BACKGROUND: Serotonergic abnormalities are hypothesized to contribute to obsessive-compulsive disorder (OCD). This study used positron emission tomography with the radioligand [11C]MDL 100907 to examine whether the distribution of serotonin 2A (5-HT(2A)) receptors is altered in OCD. METHODS: Nineteen OCD subjects, free of psychiatric medications and depression, and 19 matched healthy subjects underwent positron emission tomography scans following injection of [11C]MDL 100907. Total distribution volumes were derived by kinetic analysis using the arterial input function. Two measures of 5-HT(2A) availability were computed: the ratio at equilibrium of specifically bound radiotracer either to nondisplaceable radiotracer in tissue (BP(ND)) or to unmetabolized tracer in arterial plasma (BP(p)). Groups were compared using a region of interest (ROI) analysis and voxelwise analysis of spatially normalized parametric maps. ROIs included cortical (orbitofrontal, dorsolateral prefrontal, medial prefrontal, anterior cingulate, temporal, parietal, occipital, and insular cortex) and limbic (entorhinal cortex, parahippocampal gyrus, and medial temporal lobe) regions. RESULTS: No significant group differences were observed in [11C]MDL 100907 BP(ND) or BP(p) in the ROIs or in the voxelwise analysis of BP(ND) maps. There was a significant correlation in the orbitofrontal cortex between [11C]MDL 100907 binding and age of onset, with earlier age of onset associated with higher binding. CONCLUSIONS: Adults with OCD are not characterized as a group by major changes in 5-HT(2A) availability in cortical or limbic brain regions. Further research is warranted to examine potential differences in 5-HT(2A) availability between early- and late-onset OCD and to assess 5-HT(2A) function in relation to other neurotransmitter systems implicated in OCD.
BACKGROUND: Serotonergic abnormalities are hypothesized to contribute to obsessive-compulsive disorder (OCD). This study used positron emission tomography with the radioligand [11C]MDL 100907 to examine whether the distribution of serotonin 2A (5-HT(2A)) receptors is altered in OCD. METHODS: Nineteen OCD subjects, free of psychiatric medications and depression, and 19 matched healthy subjects underwent positron emission tomography scans following injection of [11C]MDL 100907. Total distribution volumes were derived by kinetic analysis using the arterial input function. Two measures of 5-HT(2A) availability were computed: the ratio at equilibrium of specifically bound radiotracer either to nondisplaceable radiotracer in tissue (BP(ND)) or to unmetabolized tracer in arterial plasma (BP(p)). Groups were compared using a region of interest (ROI) analysis and voxelwise analysis of spatially normalized parametric maps. ROIs included cortical (orbitofrontal, dorsolateral prefrontal, medial prefrontal, anterior cingulate, temporal, parietal, occipital, and insular cortex) and limbic (entorhinal cortex, parahippocampal gyrus, and medial temporal lobe) regions. RESULTS: No significant group differences were observed in [11C]MDL 100907 BP(ND) or BP(p) in the ROIs or in the voxelwise analysis of BP(ND) maps. There was a significant correlation in the orbitofrontal cortex between [11C]MDL 100907 binding and age of onset, with earlier age of onset associated with higher binding. CONCLUSIONS: Adults with OCD are not characterized as a group by major changes in 5-HT(2A) availability in cortical or limbic brain regions. Further research is warranted to examine potential differences in 5-HT(2A) availability between early- and late-onset OCD and to assess 5-HT(2A) function in relation to other neurotransmitter systems implicated in OCD.
Authors: Diane E Dickel; Jeremy Veenstra-VanderWeele; Nancy J Cox; Xiaolin Wu; Daniel J Fischer; Michelle Van Etten-Lee; Joseph A Himle; Bennett L Leventhal; Edwin H Cook; Gregory L Hanna Journal: Arch Gen Psychiatry Date: 2006-07
Authors: Diane E Dickel; Jeremy Veenstra-VanderWeele; Nancy Chiu Bivens; Xiaolin Wu; Daniel J Fischer; Michelle Van Etten-Lee; Joseph A Himle; Bennett L Leventhal; Edwin H Cook; Gregory L Hanna Journal: Biol Psychiatry Date: 2007-02-01 Impact factor: 13.382
Authors: P Z Tan; R M Baldwin; C H Van Dyck; M Al-Tikriti; B Roth; N Khan; D S Charney; R B Innis Journal: Nucl Med Biol Date: 1999-08 Impact factor: 2.408
Authors: Karen H Adams; Elsebeth S Hansen; Lars H Pinborg; Steen G Hasselbalch; Claus Svarer; Søren Holm; Tom G Bolwig; Gitte M Knudsen Journal: Int J Neuropsychopharmacol Date: 2005-04-01 Impact factor: 5.176
Authors: A Okasha; M Rafaat; N Mahallawy; G El Nahas; A S El Dawla; M Sayed; S El Kholi Journal: Acta Psychiatr Scand Date: 2000-04 Impact factor: 6.392
Authors: A Abi-Dargham; D Martinez; O Mawlawi; N Simpson; D R Hwang; M Slifstein; S Anjilvel; J Pidcock; N N Guo; I Lombardo; J J Mann; R Van Heertum; C Foged; C Halldin; M Laruelle Journal: J Cereb Blood Flow Metab Date: 2000-02 Impact factor: 6.200
Authors: Christopher Pittenger; Thomas G Adams; Jean-Dominique Gallezot; Michael J Crowley; Nabeel Nabulsi; Hong Gao; Stephen A Kichuk; Ryan Simpson; Eileen Billingslea; Jonas Hannestad; Michael Bloch; Linda Mayes; Zubin Bhagwagar; Richard E Carson Journal: J Affect Disord Date: 2016-02-09 Impact factor: 4.839
Authors: David Pagliaccio; Rachel Middleton; Dianne Hezel; Shari Steinman; Ivar Snorrason; Marina Gershkovich; Raphael Campeas; Anthony Pinto; Page Van Meter; H Blair Simpson; Rachel Marsh Journal: Proc Natl Acad Sci U S A Date: 2019-09-23 Impact factor: 11.205
Authors: Helen B Simpson; Dikoma C Shungu; James Bender; Xiangling Mao; Xiaoyan Xu; Mark Slifstein; Lawrence S Kegeles Journal: Neuropsychopharmacology Date: 2012-08-01 Impact factor: 7.853
Authors: A Merchán; S V Navarro; A B Klein; S Aznar; L Campa; C Suñol; M Moreno; P Flores Journal: Psychopharmacology (Berl) Date: 2017-03-09 Impact factor: 4.530
Authors: Jennifer I Lissemore; Debbie Sookman; Paul Gravel; Alexandre Berney; Amir Barsoum; Mirko Diksic; Thomas E Nordahl; Gilbert Pinard; Igor Sibon; Jean Cottraux; Marco Leyton; Chawki Benkelfat Journal: Transl Psychiatry Date: 2018-04-18 Impact factor: 6.222